Inhibitory Role of Plasminogen Activator Inhibitor-1 in Invasion and Proliferation of HLE Hepatocellular Carcinoma Cells
- 1 July 1999
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 90 (7) , 747-752
- https://doi.org/10.1111/j.1349-7006.1999.tb00810.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Plasminogen/Plasminogen Activator and Growth Factor ActivationPublished by Wiley ,2007
- Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.Journal of Clinical Investigation, 1997
- Expression of urokinase-type plasminogen activator receptor in hepatocellular carcinomaHepatology, 1997
- Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.Journal of Clinical Investigation, 1995
- The urokinase inhibitor p‐aminobenzamidine inhibits growth of a human prostate tumor in scid miceInternational Journal of Cancer, 1995
- Tissue-type plasminogen activator-induced invasion and metastasis of murine melanomasCurrent Eye Research, 1995
- ReviewBiological Chemistry Hoppe-Seyler, 1995
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991
- Plasminogen activator inhibitors: hormonally regulated serpinsMolecular and Cellular Endocrinology, 1990
- Proteolytic degradation of extracellular matrix in tumor invasionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1987